Literature DB >> 17389445

Contraception in Canada: a review of method choices, characteristics, adherence and approaches to counselling.

William A Fisher1, Amanda Black.   

Abstract

Contraception is a significant concern for Canadian women of child-bearing age, their partners and their health care providers. In this narrative review we provide information on current trends and recent changes in Canadians' choices of contraceptive methods. We review the characteristics of contraceptive methods available in Canada, with an emphasis on hormonal methods and newer options such as the transdermal contraceptive patch, the vaginal contraceptive ring and the levonorgestrel-releasing intrauterine system. We also discuss adherence to contraception as well as approaches to counselling to promote adherence and to reduce the risk of sexually transmitted infections in the context of contraception.

Entities:  

Mesh：

Year:  2007        PMID： 17389445      PMCID： PMC1828173          DOI： 10.1503/cmaj.060851

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


  46 in total

1.  Use of placebo controls in an oral contraceptive trial: methodological issues and adverse event incidence.

Authors:  G Redmond; A J Godwin; W Olson; J S Lippman
Journal:  Contraception       Date:  1999-08       Impact factor: 3.375

2.  Efficacy, cycle control, and side effects of low- and lower-dose oral contraceptives: a randomized trial of 20 micrograms and 35 micrograms estrogen preparations.

Authors:  M J Rosenberg; A Meyers; V Roy
Journal:  Contraception       Date:  1999-12       Impact factor: 3.375

Review 3.  Oral contraceptives and the risk of venous thrombosis.

Authors:  J P Vandenbroucke; J Rosing; K W Bloemenkamp; S Middeldorp; F M Helmerhorst; B N Bouma; F R Rosendaal
Journal:  N Engl J Med       Date:  2001-05-17       Impact factor: 91.245

Review 4.  Antibiotic prophylaxis for intrauterine contraceptive device insertion.

Authors:  D A Grimes; K F Schulz
Journal:  Cochrane Database Syst Rev       Date:  2001

Review 5.  Mechanism of action of hormonal preparations used for emergency contraception: a review of the literature.

Authors:  H B Croxatto; L Devoto; M Durand; E Ezcurra; F Larrea; C Nagle; M E Ortiz; D Vantman; M Vega; H von Hertzen
Journal:  Contraception       Date:  2001-03       Impact factor: 3.375

6.  Unwanted teenage pregnancies: incidence, interpretation, and intervention.

Authors:  D Byrne; K Kelley; W A Fisher
Journal:  Appl Prev Psychol       Date:  1993

7.  Low dose mifepristone and two regimens of levonorgestrel for emergency contraception: a WHO multicentre randomised trial.

Authors:  Helena von Hertzen; Gilda Piaggio; Juhong Ding; Junling Chen; Si Song; György Bártfai; Ernest Ng; Kristina Gemzell-Danielsson; Amindavaa Oyunbileg; Shangchun Wu; Weiyu Cheng; Frank Lüdicke; Alenka Pretnar-Darovec; Rosemary Kirkman; Suneeta Mittal; Archil Khomassuridze; Dan Apter; Alexandre Peregoudov
Journal:  Lancet       Date:  2002-12-07       Impact factor: 79.321

8.  Efficacy, tolerability and acceptability of a novel contraceptive vaginal ring releasing etonogestrel and ethinyl oestradiol.

Authors:  F J Roumen; D Apter; T M Mulders; T O Dieben
Journal:  Hum Reprod       Date:  2001-03       Impact factor: 6.918

9.  Effectiveness of emergency contraceptive pills between 72 and 120 hours after unprotected sexual intercourse.

Authors:  I Rodrigues; F Grou; J Joly
Journal:  Am J Obstet Gynecol       Date:  2001-03       Impact factor: 8.661

10.  Oral contraceptives and venous thromboembolism: a five-year national case-control study.

Authors:  Øjvind Lidegaard; Birgitte Edström; Svend Kreiner
Journal:  Contraception       Date:  2002-03       Impact factor: 3.375
View more
  6 in total

1.  Risks of venous thromboembolism with various hormonal contraceptives.

Authors:  G Michael Allan; Sudha Koppula
Journal:  Can Fam Physician       Date:  2012-10       Impact factor: 3.275

2.  Barriers and facilitators to family planning access in Canada.

Authors:  Jennifer Hulme; Sheila Dunn; Edith Guilbert; Judith Soon; Wendy Norman
Journal:  Healthc Policy       Date:  2015-02

3.  HIV/AIDS Counseling Skills and Strategies: Can Testing and Counseling Curb the Epidemic?

Authors:  Amar Shireesh Kanekar
Journal:  Int J Prev Med       Date:  2011-01

4.  Becoming a 'pharmaceutical person': Medication use trajectories from age 26 to 38 in a representative birth cohort from Dunedin, New Zealand.

Authors:  Peri J Ballantyne; Pauline Norris; Venkata Praveen Parachuru; W Murray Thomson
Journal:  SSM Popul Health       Date:  2017-11-12

5.  Multisite Study of Women Living With HIV's Perceived Barriers to, and Interest in, Long-Acting Injectable Antiretroviral Therapy.

Authors:  Morgan M Philbin; Carrigan L Parish; Elizabeth N Kinnard; Sarah E Reed; Deanna Kerrigan; Maria L Alcaide; Mardge H Cohen; Oluwakemi Sosanya; Anandi N Sheth; Adaora A Adimora; Jennifer Cocohoba; Lakshmi Goparaju; Elizabeth T Golub; Margaret Fischl; Lisa R Metsch
Journal:  J Acquir Immune Defic Syndr       Date:  2020-07-01       Impact factor: 3.771

6.  Characteristics and contributory factors for injectable contraceptive usage among women in Kumasi, Ghana.

Authors:  Dennis Odai Laryea; Frank Ankobeah; Emmanuel S K Morhe; Yaw Ampem Amoako; Kathryn Spangenberg
Journal:  Contracept Reprod Med       Date:  2016-05-26
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.